Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors-Reference-Cited by-同舟云学术

Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors

Published:2019-11-20 Issue:1 Volume:26 Page:41-46
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Ebbert Patrick T.¹,Xavier Frederico¹²,Seaman Craig D.¹^ORCID,Ragni Margaret V.¹^ORCID

Affiliation:

1. Department of Medicine and Hemophilia Center of Western PA University of Pittsburgh Pittsburgh PA USA

2. Children’s Hospital of Pittsburgh University of Pittsburgh Pittsburgh PA USA

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13877

Reference22 articles.

1. Centers for Disease Control and Prevention.Bleeding and clotting disorders surveillance. Summary report of UDC activity.http://www2a.cdc.gov/ncbddd/htcweb/index.asp accessed July 11 2019.

2. Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices

3. Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

4. Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia

5. Pharmaco-economic aspects of inhibitor treatment

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of joint health in patients receiving prophylaxis for haemophilia A: a cross-sectional survey in five European countries;BMJ Open;2024-09

2. Emicizumab is well tolerated and effective in people with congenital hemophilia A regardless of age, severity of disease, or inhibitor status: a scoping review;Research and Practice in Thrombosis and Haemostasis;2024-05

3. Bleeding control improves after switching to emicizumab: Real‐world experience of 177 children in the PedNet registry;Haemophilia;2024-04-05

4. How much prophylaxis is enough in haemophilia?;Haemophilia;2024-03-24

5. Intraindividual bleeding outcomes in patients with hemophilia A on emicizumab prophylaxis in Australia;Blood Vessels, Thrombosis & Hemostasis;2024-03